Absorption and Antioxidant Effects of Quercetin from Onions, in Man
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Effect of the Flavonoids Quercetin and Genistein on The
THE EFFECT OF THE FLAVONOIDS QUERCETIN AND GENISTEIN ON THE ANTIOXIDANT ENZYMES Cu, Zn SUPEROXIDE DISMUTASE, GLUTATHIONE PEROXIDASE, AND GLUTATHIONE REDUCTASE IN MALE SPRAGUE-DAWLEY RATS by ANNETTE CAIRNS GOVERNO (Under the Direction of Joan G. Fischer) ABSTRACT Quercetin (QC) and genistein (GS) are phytochemicals found in fruits and vegetables. These compounds may exert protective effects by altering antioxidant enzyme activities. The objective of the study was to examine the effects of QC and GS supplementation on the activities of the antioxidant enzymes glutathione reductase (GR), glutathione peroxidase (GSHPx), and Cu, Zn superoxide dismutase (SOD) in liver, and SOD activity in red blood cells (RBC), as well as the Ferric Reducing Antioxidant Potential (FRAP). Male, weanling Sprague-Dawley rats (n=7-8 group) were fed quercetin at 0.3, 0.6 or 0.9g/100g of diet or genistein at 0.008, 0.012, or 0.02g/100g diet for 14d. GS supplementation significantly increased liver GSHPx activity compared to control (p<0.01). GS did not significantly alter activities of liver SOD and GR, or RBC SOD. QC did not significantly alter antioxidant enzyme activities in liver or RBC. Neither QC nor GS increased the antioxidant capacity of serum. In conclusion, low levels of GS significantly increased liver GSHPx activity, which may contribute to this isoflavone’s protective effects. INDEX WORDS: Flavonoids, Quercetin, Genistein, Copper Zinc Superoxide Dismutase, Glutathione Peroxidase, Glutathione Reductase THE EFFECT OF THE FLAVONOIDS QUERCETIN AND GENISTEIN ON THE ANTIOXIDANT ENZYMES Cu, Zn SUPEROXIDE DISMUTASE, GLUTATHIONE PEROXIDASE, AND GLUTATHIONE REDUCTASE IN MALE SPRAGUE-DAWLEY RATS by ANNETTE CAIRNS GOVERNO B., S. -
In Vivo Analysis of Bisphenol
Asian Journal of Pharmacy and Pharmacology 2019; 5(S1): 28-36 28 Research Article In vivo analysis of bisphenol A-induced sub-chronic toxicity on reproductive accessory glands of male mice and its amelioration by quercetin Sanman Samova, Hetal Doctor, Dimple Damore, Ramtej Verma Department of Zoology, BMTC and Human Genetics, School of Sciences, Gujarat University, Ahmedabad, India Received: 20 December 2018 Revised: 1 February 2019 Accepted: 25 February 2019 Abstract Objective: Bisphenol A is an endocrine disrupting chemical, widely used as a material for the production of epoxy resins and polycarbonate plastics. Food is considered as the main source of exposure to BPA as it leaches out from the food containers as well as surface coatings into it. BPA is toxic to vital organs such as liver kidney and brain. Quercetin, the most abundant flavonoid in nature, is present in large amounts in vegetables, fruits and tea. The aim of the present study was to evaluate the toxic effects of BPA in prostate gland and seminal vesicle of mice and its possible amelioration by quercetin. Material and methods: Inbred Swiss strain male albino mice were orally administered with BPA (80, 120 and 240 mg/kg body weight/day) for 45 Days. Oral administration of BPA caused significant, dose-dependent reduction in absolute and relative weights of prostate gland and seminal vesicle. Results and conclusion: Biochemical analysis revealed that protein content reduced significantly, whereas acid phosphatase activity increased significantly in prostate gland and reduction in fructose content was observed in seminal vesicle. Oral administration of quercetin (30, 60 and 90 mg/kg body weight/day) alone with high dose of BPA (240 mg/kg body weight/day) for 45 days caused significant and dose-dependent amelioration in all parameters as compared to BPA along treated group. -
Fighting Bisphenol A-Induced Male Infertility: the Power of Antioxidants
antioxidants Review Fighting Bisphenol A-Induced Male Infertility: The Power of Antioxidants Joana Santiago 1 , Joana V. Silva 1,2,3 , Manuel A. S. Santos 1 and Margarida Fardilha 1,* 1 Department of Medical Sciences, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal; [email protected] (J.S.); [email protected] (J.V.S.); [email protected] (M.A.S.S.) 2 Institute for Innovation and Health Research (I3S), University of Porto, 4200-135 Porto, Portugal 3 Unit for Multidisciplinary Research in Biomedicine, Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal * Correspondence: [email protected]; Tel.: +351-234-247-240 Abstract: Bisphenol A (BPA), a well-known endocrine disruptor present in epoxy resins and poly- carbonate plastics, negatively disturbs the male reproductive system affecting male fertility. In vivo studies showed that BPA exposure has deleterious effects on spermatogenesis by disturbing the hypothalamic–pituitary–gonadal axis and inducing oxidative stress in testis. This compound seems to disrupt hormone signalling even at low concentrations, modifying the levels of inhibin B, oestra- diol, and testosterone. The adverse effects on seminal parameters are mainly supported by studies based on urinary BPA concentration, showing a negative association between BPA levels and sperm concentration, motility, and sperm DNA damage. Recent studies explored potential approaches to treat or prevent BPA-induced testicular toxicity and male infertility. Since the effect of BPA on testicular cells and spermatozoa is associated with an increased production of reactive oxygen species, most of the pharmacological approaches are based on the use of natural or synthetic antioxidants. -
Mechanisms of Toxic Action of the Flavonoid Quercetin and Its Phase II Metabolites
Mechanisms of toxic action of the flavonoid quercetin and its phase II metabolites Hester van der Woude Promotor: Prof. Dr. Ir. I.M.C.M. Rietjens Hoogleraar in de Toxicologie Wageningen Universiteit Co-promotor: Dr. G.M. Alink Universitair Hoofddocent, Sectie Toxicologie Wageningen Universiteit. Promotiecommissie: Prof. Dr. A. Bast Universiteit Maastricht Dr. Ir. P.C.H. Hollman RIKILT Instituut voor Voedselveiligheid, Wageningen Prof. Dr. Ir. F.J. Kok Wageningen Universiteit Prof. Dr. T. Walle Medical University of South Carolina, Charleston, SC, USA Dit onderzoek is uitgevoerd binnen de onderzoekschool VLAG Mechanisms of toxic action of the flavonoid quercetin and its phase II metabolites Hester van der Woude Proefschrift ter verkrijging van de graad van doctor op gezag van de rector magnificus van Wageningen Universiteit, Prof. Dr. M.J. Kropff, in het openbaar te verdedigen op vrijdag 7 april 2006 des namiddags te half twee in de Aula Title Mechanisms of toxic action of the flavonoid quercetin and its phase II metabolites Author Hester van der Woude Thesis Wageningen University, Wageningen, the Netherlands (2006) with abstract, with references, with summary in Dutch. ISBN 90-8504-349-2 Abstract During and after absorption in the intestine, quercetin is extensively metabolised by the phase II biotransformation system. Because the biological activity of flavonoids is dependent on the number and position of free hydroxyl groups, a first objective of this thesis was to investigate the consequences of phase II metabolism of quercetin for its biological activity. For this purpose, a set of analysis methods comprising HPLC-DAD, LC-MS and 1H NMR proved to be a useful tool in the identification of the phase II metabolite pattern of quercetin in various biological systems. -
Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr
Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Crizotinib (PF-02341066) 1 4 55 Docetaxel 1 5 98 Anastrozole 1 6 25 Cladribine 1 7 23 Methotrexate 1 8 -187 Letrozole 1 9 65 Entecavir Hydrate 1 10 48 Roxadustat (FG-4592) 1 11 19 Imatinib Mesylate (STI571) 1 12 0 Sunitinib Malate 1 13 34 Vismodegib (GDC-0449) 1 14 64 Paclitaxel 1 15 89 Aprepitant 1 16 94 Decitabine 1 17 -79 Bendamustine HCl 1 18 19 Temozolomide 1 19 -111 Nepafenac 1 20 24 Nintedanib (BIBF 1120) 1 21 -43 Lapatinib (GW-572016) Ditosylate 1 22 88 Temsirolimus (CCI-779, NSC 683864) 1 23 96 Belinostat (PXD101) 1 24 46 Capecitabine 1 25 19 Bicalutamide 1 26 83 Dutasteride 1 27 68 Epirubicin HCl 1 28 -59 Tamoxifen 1 29 30 Rufinamide 1 30 96 Afatinib (BIBW2992) 1 31 -54 Lenalidomide (CC-5013) 1 32 19 Vorinostat (SAHA, MK0683) 1 33 38 Rucaparib (AG-014699,PF-01367338) phosphate1 34 14 Lenvatinib (E7080) 1 35 80 Fulvestrant 1 36 76 Melatonin 1 37 15 Etoposide 1 38 -69 Vincristine sulfate 1 39 61 Posaconazole 1 40 97 Bortezomib (PS-341) 1 41 71 Panobinostat (LBH589) 1 42 41 Entinostat (MS-275) 1 43 26 Cabozantinib (XL184, BMS-907351) 1 44 79 Valproic acid sodium salt (Sodium valproate) 1 45 7 Raltitrexed 1 46 39 Bisoprolol fumarate 1 47 -23 Raloxifene HCl 1 48 97 Agomelatine 1 49 35 Prasugrel 1 50 -24 Bosutinib (SKI-606) 1 51 85 Nilotinib (AMN-107) 1 52 99 Enzastaurin (LY317615) 1 53 -12 Everolimus (RAD001) 1 54 94 Regorafenib (BAY 73-4506) 1 55 24 Thalidomide 1 56 40 Tivozanib (AV-951) 1 57 86 Fludarabine -
The Human Microbial Metabolism of Quercetin in Different Formulations
foods Article The human Microbial Metabolism of Quercetin in Different Formulations: An In Vitro Evaluation Giuseppe Di Pede 1 , Letizia Bresciani 2 , Luca Calani 1, Giovanna Petrangolini 3 , Antonella Riva 3 , Pietro Allegrini 3, Daniele Del Rio 2,* and Pedro Mena 1 1 Department of Food and Drugs, University of Parma, 43124 Parma, Italy; [email protected] (G.D.P.); [email protected] (L.C.); [email protected] (P.M.) 2 Department of Veterinary Science, University of Parma, 43126 Parma, Italy; [email protected] 3 Research and Development Department, Indena S.p.A., Viale Ortles, 12-20139 Milano, Italy; [email protected] (G.P.); [email protected] (A.R.); [email protected] (P.A.) * Correspondence: [email protected]; Tel.: +39-0521-033830 Received: 29 July 2020; Accepted: 10 August 2020; Published: 14 August 2020 Abstract: Quercetin is one of the main dietary flavonols, but its beneficial properties in disease prevention may be limited due to its scarce bioavailability. For this purpose, delivery systems have been designed to enhance both stability and bioavailability of bioactive compounds. This study aimed at investigating the human microbial metabolism of quercetin derived from unformulated and phytosome-formulated quercetin through an in vitro model. Both ingredients were firstly characterized for their profile in native (poly)phenols, and then fermented with human fecal microbiota for 24 h. Quantification of microbial metabolites was performed by ultra-high performance liquid chromatography coupled to mass spectrometry (uHPLC-MSn) analyses. Native quercetin, the main compound in both products, appeared less prone to microbial degradation in the phytosome-formulated version compared to the unformulated one during fecal incubation. -
Phytochem Referenzsubstanzen
High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.286. ABIETIC ACID Sylvic acid [514-10-3] 302.46 C20H30O2 01.030. L-ABRINE N-a-Methyl-L-tryptophan [526-31-8] 218.26 C12H14N2O2 Merck Index 11,5 01.031. (+)-ABSCISIC ACID [21293-29-8] 264.33 C15H20O4 Merck Index 11,6 01.032. (+/-)-ABSCISIC ACID ABA; Dormin [14375-45-2] 264.33 C15H20O4 Merck Index 11,6 01.002. ABSINTHIN Absinthiin, Absynthin [1362-42-1] 496,64 C30H40O6 Merck Index 12,8 01.033. ACACETIN 5,7-Dihydroxy-4'-methoxyflavone; Linarigenin [480-44-4] 284.28 C16H12O5 Merck Index 11,9 01.287. ACACETIN Apigenin-4´methylester [480-44-4] 284.28 C16H12O5 01.034. ACACETIN-7-NEOHESPERIDOSIDE Fortunellin [20633-93-6] 610.60 C28H32O14 01.035. ACACETIN-7-RUTINOSIDE Linarin [480-36-4] 592.57 C28H32O14 Merck Index 11,5376 01.036. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- a-D-Glucosamine pentaacetate 389.37 C16H23NO10 ACETYL-a-D-GLUCOPYRANOSE 01.037. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- b-D-Glucosamine pentaacetate [7772-79-4] 389.37 C16H23NO10 ACETYL-b-D-GLUCOPYRANOSE> 01.038. 2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL- Acetochloro-a-D-glucosamine [3068-34-6] 365.77 C14H20ClNO8 a-D-GLUCOPYRANOSYLCHLORIDE - 1 - High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.039. -
Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11: in Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary
nutrients Article Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11: In Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary Flavonoids 1,2, 2, , 1 1 1 Hiroki Saito y, Yu Toyoda * y , Hiroshi Hirata , Ami Ota-Kontani , Youichi Tsuchiya , Tappei Takada 2 and Hiroshi Suzuki 2 1 Frontier Laboratories for Value Creation, Sapporo Holdings Ltd., 10 Okatome, Yaizu, Shizuoka 425-0013, Japan; [email protected] (H.S.); [email protected] (H.H.); [email protected] (A.O.-K.); [email protected] (Y.T.) 2 Department of Pharmacy, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; [email protected] (T.T.); [email protected] (H.S.) * Correspondence: [email protected] These authors contributed equally to this work. y Received: 2 July 2020; Accepted: 12 August 2020; Published: 14 August 2020 Abstract: Axillary osmidrosis (AO) is a common chronic skin condition characterized by unpleasant body odors emanating from the armpits, and its aetiology is not fully understood. AO can seriously impair the psychosocial well-being of the affected individuals; however, no causal therapy has been established for it other than surgical treatment. Recent studies have revealed that human ATP-binding cassette transporter C11 (ABCC11) is an AO risk factor when it is expressed in the axillary apocrine glands—the sources of the offensive odors. Hence, identifying safe ways to inhibit ABCC11 may offer a breakthrough in treating AO. We herein screened for ABCC11-inhibitory activities in 34 natural products derived from plants cultivated for human consumption using an in vitro assay system to measure the ABCC11-mediated transport of radiolabeled dehydroepiandrosterone sulfate (DHEA-S—an ABCC11 substrate). -
During This Time of Great Societal Stress, We Are Here to Contribute Our Knowledge and Experience to Your Health and Wellbeing
During this time of great societal stress, we are here to contribute our knowledge and experience to your health and wellbeing. There is a high level of interest in evidence-based integrative strategies to augment public health measures to prevent COVID-19 virus infection and associated pneumonia. Unfortunately, no integrative measures have been validated in human trials specifically for COVID-19. Notwithstanding, this is an opportune time to be proactive. Using available evidence, we offer the following strategies for you to consider to enhance your immune system to reduce the severity or the duration of a viral infection. Again, we stress that these are supplemental considerations to the current recommendations that emphasize regular hand washing, physical distancing, stopping non-essential travel, and getting tested if you develop symptoms. RISK REDUCTION: • Adequate sleep: Shorter sleep duration increases the risk of infectious illness. Adequate sleep also ensures the secretion of melatonin, a molecule which may play a role in reducing coronavirus virulence (see Melatonin below). • Stress management: Psychological stress disrupts immune regulation. Various mindfulness techniques such as meditation, breathing exercises, and guided imagery reduce stress. • Zinc: Coronaviruses appear to be susceptible to the viral inhibitory actions of zinc. Zinc may prevent coronavirus entry into cells and appears to reduce coronavirus virulence. Typical daily dosing of zinc is 15mg – 30mg daily with lozenges potentially providing direct protective effects in the upper respiratory tract. • Vegetables and Fruits: Vegetables and fruits provide a repository of flavonoids that are considered a cornerstone of an anti-inflammatory diet. At least 5–7 servings of vegetables and 2–3 servings of fruits are recommended daily. -
Inhibitory Effect of Acacetin, Apigenin, Chrysin and Pinocembrin on Human Cytochrome P450 3A4
ORIGINAL SCIENTIFIC PAPER Croat. Chem. Acta 2020, 93(1), 33–39 Published online: August 03, 2020 DOI: 10.5562/cca3652 Inhibitory Effect of Acacetin, Apigenin, Chrysin and Pinocembrin on Human Cytochrome P450 3A4 Martin Kondža,1 Hrvoje Rimac,2,3 Željan Maleš,4 Petra Turčić,5 Ivan Ćavar,6 Mirza Bojić2,* 1 University of Mostar, Faculty of Pharmacy, Matice hrvatske bb, 88000 Mostar, Bosnia and Herzegovina 2 University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, A. Kovačića 1, 10000 Zagreb, Croatia 3 South Ural State University, Higher Medical and Biological School, Laboratory of Computational Modeling of Drugs, 454000 Chelyabinsk, Russian Federation 4 University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Botany, Schrottova 39, 10000 Zagreb, Croatia 5 University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmacology, Domagojeva 2, 10000 Zagreb, Croatia 6 University of Mostar, Faculty of Medicine, Kralja Petra Krešimira IV bb, 88000 Mostar, Bosnia and Herzegovina * Corresponding author’s e-mail address: [email protected] RECEIVED: June 26, 2020 REVISED: July 28, 2020 ACCEPTED: July 30, 2020 Abstract: Cytochrome P450 3A4 is the most significant enzyme in metabolism of medications. Flavonoids are common secondary plant metabolites found in fruits and vegetables. Some flavonoids can interact with other drugs by inhibiting cytochrome P450 enzymes. Thus, the objective of this study was to determine inhibition kinetics of cytochrome P450 3A4 by flavonoids: acacetin, apigenin, chrysin and pinocembrin. For this purpose, testosterone was used as marker substrate, and generation of the 6β-hydroxy metabolite was monitored by high performance liquid chromatography coupled with diode array detector. -
Cphi & P-MEC China Exhibition List展商名单version版本20180116
CPhI & P-MEC China Exhibition List展商名单 Version版本 20180116 Booth/ Company Name/公司中英文名 Product/产品 展位号 Carbosynth Ltd E1A01 Toronto Research Chemicals Inc E1A08 SiliCycle Inc. E1A10 SA TOURNAIRE E1A11 Indena SpA E1A17 Trifarma E1A21 LLC Velpharma E1A25 Anuh Pharma E1A31 Chemclone Industries E1A51 Hetero Labs Limited E1B09 Concord Biotech Limited E1B10 ScinoPharm Taiwan Ltd E1B11 Dongkook Pharmaceutical Co., Ltd. E1B19 Shenzhen Salubris Pharmaceuticals Co., Ltd E1B22 GfM mbH E1B25 Leawell International Ltd E1B28 DCS Pharma AG E1B31 Agno Pharma E1B32 Newchem Spa E1B35 APEX HEALTHCARE LIMITED E1B51 AMRI E1C21 Aarti Drugs Limited E1C25 Espee Group Innovators E1C31 Ruland Chemical Co., Ltd. E1C32 Merck Chemicals (Shanghai) Co., Ltd. E1C51 Mediking Pharmaceutical Group Ltd E1C57 珠海联邦制药股份有限公司/The United E1D01 Laboratories International Holdings Ltd. FMC Corporation E1D02 Kingchem (Liaoning) Chemical Co., Ltd E1D10 Doosan Corporation E1D22 Sunasia Co., Ltd. E1D25 Bolon Pharmachem Co., Ltd. E1D26 Savior Lifetec Corporation E1D27 Alchem International Pvt Ltd E1D31 Polish Investment and Trade Agency E1D57 Fischer Chemicals AG E1E01 NGL Fine Chem Limited E1E24 常州艾柯轧辊有限公司/ECCO Roller E1E25 Linnea SA E1E26 Everlight Chemical Industrial Corporation E1E27 HARMAN FINOCHEM E1E28 Zhechem Co Ltd E1F01 Midas Pharma GmbH Shanghai Representativ E1F03 Supriya Lifescience Ltd E1F10 KOA Shoji Co Ltd E1F22 NOF Corporation E1F24 上海贺利氏工业技术材料有限公司/Heraeus E1F26 Materials Technology Shanghai Ltd. Novacyl Asia Pacific Ltd E1F28 PharmSol Europe Limited E1F32 Bachem AG E1F35 Louston International Inc. E1F51 High Science Co Ltd E1F55 Chemsphere Technology Inc. E1F57a PharmaCore Biotech Co., Ltd. E1F57b Rockwood Lithium GmbH E1G51 Sarv Bio Labs Pvt Ltd E1G57 抗病毒类、抗肿瘤类、抗感染类和甾体类中间体、原料药和药物制剂及医药合约研发和加工服务 上海创诺医药集团有限公司/Shanghai Desano APIs and Finished products of ARV, Oncology, Anti-infection and Hormone drugs and E1H01 Pharmaceuticals Co., Ltd. -
Review Article Interactions Between CYP3A4 and Dietary Polyphenols
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Crossref Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2015, Article ID 854015, 15 pages http://dx.doi.org/10.1155/2015/854015 Review Article Interactions between CYP3A4 and Dietary Polyphenols Loai Basheer and Zohar Kerem Institute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, P.O. Box 12, 76100 Rehovot, Israel Correspondence should be addressed to Zohar Kerem; [email protected] Received 14 October 2014; Revised 15 December 2014; Accepted 19 December 2014 Academic Editor: Cristina Angeloni Copyright © 2015 L. Basheer and Z. Kerem. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ThehumancytochromeP450enzymes(P450s)catalyzeoxidativereactionsofabroadspectrumofsubstratesandplayacritical role in the metabolism of xenobiotics, such as drugs and dietary compounds. CYP3A4 is known to be the main enzyme involved in the metabolism of drugs and most other xenobiotics. Dietary compounds, of which polyphenolics are the most studied, have been shown to interact with CYP3A4 and alter its expression and activity. Traditionally, the liver was considered the prime site of CYP3A-mediated first-pass metabolic extraction, but in vitro and in vivo studies now suggest that the small intestine can be of equal or even greater importance for the metabolism of polyphenolics and drugs. Recent studies have pointed to the role of gut microbiota in the metabolic fate of polyphenolics in human, suggesting their involvement in the complex interactions between dietary polyphenols and CYP3A4.